BDMS TB- Revised Down Earnings Forecasts to Reflect Weak Foreign Patient Numbers

132 Views20 Nov 2024 19:34
Broker
We downgrade our rating to Neutral (previously Outperform), with a more negative view on the fundamentals. This is due to the expected 2024-26E EPS growth of just a +5% CAGR
What is covered in the Full Insight:
  • Company Overview
  • Latest Performance
  • Future Earnings Outlook
  • Market Analysis
  • Investment Considerations
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 13-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Krungthai XSpring
A full service Thai brokerage
ThailandEquities
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x